Lv6
1930 积分 2022-09-12 加入
Charge variants of proposed biosimilar to Omalizumab: Isolation, purification and analysis by HPLC methods
24天前
已关闭
Characterization and pre-clinical assessment of a proposed biosimilar to its originator Omalizumab
24天前
已完结
The present and future of bispecific antibodies for cancer therapy
1个月前
已完结
Pharmaceutical Biotechnology
1个月前
已完结
Pharmaceutical Biotechnology Fundamentals and Applications sixth edition
1个月前
已关闭
Comparability strategy and demonstration for post-approval production cell line change of a bevacizumab biosimilar IBI305
1个月前
已完结
An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis
1个月前
已完结
Top product forecasts for 2024
3个月前
已完结
Antibody aggregation can lead to reduced Protein A binding capacity and low step yield
3个月前
已完结
Formulation of Monoclonal Antibody Therapies From Lab to Market
4个月前
已关闭
皖公网安备34019202002308
